We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+10.13%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$53.9B
AUM Growth
-$21B
Cap. Flow
+$1.12B
Cap. Flow %
2.08%
Top 10 Hldgs %
31.63%
Holding
3,163
New
260
Increased
1,432
Reduced
926
Closed
418

Sector Composition

Rank Sector Weight
1 Technology 8.19%
2 Financials 4.43%
3 Consumer Discretionary 2.64%
4 Healthcare 2.52%
5 Industrials 1.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDRV icon
2151
iShares Self-Driving EV and Tech ETF
IDRV
$122M
$274K ﹤0.01%
7,659
-2,088
-21% -$71.1K
NTLA icon
2152
Intellia Therapeutics
NTLA
$1.5B
$274K ﹤0.01%
8,972
+8,757
+4,073% +$252K
NEO icon
2153
NeoGenomics
NEO
$1.81B
$274K ﹤0.01%
16,904
-85,108
-83% -$1.39M
GRX
2154
Gabelli Healthcare & Wellness Trust
GRX
$141M
$273K ﹤0.01%
29,274
-2,604
-8% -$22.4K
BJRI icon
2155
BJ's Restaurants
BJRI
$1.41B
$272K ﹤0.01%
7,562
+7,517
+16,704% +$214K
GSBC icon
2156
Great Southern Bancorp
GSBC
$863M
$272K ﹤0.01%
+4,581
New +$240K
CALM icon
2157
Cal-Maine
CALM
$4.28B
$272K ﹤0.01%
+4,735
New +$234K
GLDD
2158
DELISTED
Great Lakes Dredge & Dock
GLDD
$271K ﹤0.01%
35,348
-4,473
-11% -$32.6K
SSRM icon
2159
SSR Mining
SSRM
$5.57B
$271K ﹤0.01%
25,279
-843
-3% -$10.2K
UGP icon
2160
Ultrapar
UGP
$6.87B
$271K ﹤0.01%
50,011
+37,241
+292% +$172K
GUT
2161
Gabelli Utility Trust
GUT
$576M
$270K ﹤0.01%
51,189
+1,222
+2% +$6.87K
BBH icon
2162
VanEck Biotech ETF
BBH
$396M
$270K ﹤0.01%
1,631
+1,156
+243% +$178K
IQ icon
2163
iQIYI
IQ
$1.18B
$268K ﹤0.01%
55,002
+5,793
+12% +$27.4K
GMED icon
2164
Globus Medical
GMED
$10.4B
$268K ﹤0.01%
5,036
-1,261
-20% -$61.5K
DLTH icon
2165
Duluth Holdings
DLTH
$160M
$268K ﹤0.01%
49,868
+20,355
+69% +$106K
ROG icon
2166
Rogers Corp
ROG
$2.33B
$268K ﹤0.01%
2,030
-39
-2% -$4.99K
NAD icon
2167
Nuveen Quality Municipal Income Fund
NAD
$2.71B
$268K ﹤0.01%
23,375
+19,424
+492% +$205K
OWL icon
2168
Blue Owl Capital
OWL
$6.39B
$267K ﹤0.01%
+17,950
New +$242K
OSBC icon
2169
Old Second Bancorp
OSBC
$1.24B
$267K ﹤0.01%
17,311
+1,465
+9% +$21.2K
DOCN icon
2170
DigitalOcean
DOCN
$14.4B
$267K ﹤0.01%
+7,277
New +$201K
APLS
2171
DELISTED
Apellis Pharmaceuticals
APLS
$267K ﹤0.01%
+4,460
New +$226K
NMIH icon
2172
NMI Holdings
NMIH
$3.25B
$267K ﹤0.01%
+8,994
New +$251K
BBJP icon
2173
JPMorgan BetaBuilders Japan ETF
BBJP
$17.3B
$267K ﹤0.01%
5,077
-7,112
-58% -$361K
NRGV icon
2174
Energy Vault
NRGV
$522M
$267K ﹤0.01%
114,401
-1,000
-0.9% -$2.31K
ESI icon
2175
Element Solutions
ESI
$9.12B
$267K ﹤0.01%
+11,519
New +$233K

Similar funds

Creative Planning's Q4 2023 Portfolio in Review

As of Q4 2023, Creative Planning held 3,163 positions worth $53.9B, down 28% from $74.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Creative Planning's Q4 2023 filing shows 260 new, 1,432 increased, 926 reduced and 418 closed positions. Its largest new stake was Avantis Core Fixed Income ETF: 333,301 shares worth $13.9M. The largest sale was iShares National Muni Bond ETF, an estimated $105M.

By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 5.2% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Creative Planning's largest Q4 2023 buy was Avantis Core Fixed Income ETF: 333,301 shares worth $13.9M.
  • Creative Planning added most to Vanguard Total Bond Market in Q4 2023, an estimated $395M increase.
  • Creative Planning's biggest Q4 2023 reduction was iShares National Muni Bond ETF, cutting an estimated $105M.
  • Creative Planning fully exited iShares iBonds Dec 2023 Term Corporate ETF in Q4 2023, selling an estimated $9.03M.
  • Creative Planning's ten largest holdings make up 32% of its $53.9B portfolio in Q4 2023.
  • Creative Planning opened 260 new positions and closed 418 in Q4 2023.
  • Creative Planning's portfolio value fell 28% quarter-over-quarter to $53.9B.

Based on Creative Planning's 13F filing for Q4 2023, filed 14 Feb 2024.